Header Logo

Connection

THOMAS MONATH to Neutralization Tests

Back to Details
This is a "connection" page, showing publications THOMAS MONATH has written about Neutralization Tests.
THOMAS MONATH
Connection Strength
1.226
Neutralization Tests
  1. Inactivated yellow fever 17D vaccine: development and nonclinical safety, immunogenicity and protective activity. Vaccine. 2010 May 14; 28(22):3827-40.
    View in: PubMed
    Score: 0.082
  2. Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests. Clin Vaccine Immunol. 2009 Jul; 16(7):1052-9.
    View in: PubMed
    Score: 0.078
  3. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults. Vaccine. 2009 Mar 04; 27(10):1637-44.
    View in: PubMed
    Score: 0.075
  4. Use of a surrogate chimeric virus to detect West Nile virus-neutralizing antibodies in avian and equine sera. Clin Vaccine Immunol. 2009 Jan; 16(1):134-5.
    View in: PubMed
    Score: 0.075
  5. Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge. Vaccine. 2008 Jan 24; 26(4):581-8.
    View in: PubMed
    Score: 0.070
  6. A live, attenuated recombinant West Nile virus vaccine. Proc Natl Acad Sci U S A. 2006 Apr 25; 103(17):6694-9.
    View in: PubMed
    Score: 0.063
  7. Yellow fever 17D vaccine safety and immunogenicity in the elderly. Hum Vaccin. 2005 Sep-Oct; 1(5):207-14.
    View in: PubMed
    Score: 0.060
  8. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults. Vaccine. 2005 May 09; 23(25):3301-9.
    View in: PubMed
    Score: 0.059
  9. Randomized, double-blind, phase III, pivotal field trial of the comparative immunogenicity, safety, and tolerability of two yellow fever 17D vaccines (Arilvax and YF-VAX) in healthy infants and children in Peru. Am J Trop Med Hyg. 2005 Feb; 72(2):189-97.
    View in: PubMed
    Score: 0.058
  10. Evaluation of humoral immune response after yellow fever infection: an observational study on patients from the 2017-2018 sylvatic outbreak in Brazil. Microbiol Spectr. 2024 May 02; 12(5):e0370323.
    View in: PubMed
    Score: 0.054
  11. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen. J Infect Dis. 2003 Oct 15; 188(8):1213-30.
    View in: PubMed
    Score: 0.053
  12. Clonal vaccinia virus grown in cell culture as a new smallpox vaccine. Nat Med. 2003 Sep; 9(9):1125-30.
    View in: PubMed
    Score: 0.052
  13. Development of a novel vaccinia-neutralization assay based on reporter-gene expression. J Infect Dis. 2003 Aug 01; 188(3):440-8.
    View in: PubMed
    Score: 0.052
  14. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates. J Virol. 2000 Jun; 74(12):5477-85.
    View in: PubMed
    Score: 0.042
  15. Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys. J Virol. 2000 Feb; 74(4):1742-51.
    View in: PubMed
    Score: 0.041
  16. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. Vaccine. 1999 Apr 09; 17(15-16):1869-82.
    View in: PubMed
    Score: 0.039
  17. Safety and immunogenicity of the rVSV?G-ZEBOV-GP Ebola virus vaccine candidate in healthy adults: a phase 1b randomised, multicentre, double-blind, placebo-controlled, dose-response study. Lancet Infect Dis. 2017 08; 17(8):854-866.
    View in: PubMed
    Score: 0.034
  18. Labile serum factor and its effect on arbovirus neutralization. Appl Microbiol. 1971 Jan; 21(1):79-83.
    View in: PubMed
    Score: 0.022
  19. Evaluation of the potency and safety of inactivated Japanese encephalitis vaccine in US inhabitants. J Infect Dis. 1990 May; 161(5):878-82.
    View in: PubMed
    Score: 0.021
  20. Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. J Virol. 1986 Dec; 60(3):1153-5.
    View in: PubMed
    Score: 0.016
  21. Arbovirus investigations in Argentina, 1977-1980. IV. Serologic surveys and sentinel equine program. Am J Trop Med Hyg. 1985 Sep; 34(5):966-75.
    View in: PubMed
    Score: 0.015
  22. Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis. J Clin Microbiol. 1984 Oct; 20(4):784-90.
    View in: PubMed
    Score: 0.014
  23. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine. Vaccine. 2004 Sep 09; 22(27-28):3722-6.
    View in: PubMed
    Score: 0.014
  24. Monoclonal antibodies distinguish between wild and vaccine strains of yellow fever virus by neutralization, hemagglutination inhibition, and immune precipitation of the virus envelope protein. Virology. 1983 Feb; 125(1):8-17.
    View in: PubMed
    Score: 0.013
  25. Limitations of the complement-fixation test for distinguishing naturally acquired from vaccine-induced yellow fever infection in flavivirus-hyperendemic areas. Am J Trop Med Hyg. 1980 Jul; 29(4):624-34.
    View in: PubMed
    Score: 0.010
  26. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun. 1999 Feb; 67(2):527-38.
    View in: PubMed
    Score: 0.010
  27. Cloning, expression and functional activities of a single chain antibody fragment directed to fusion protein of respiratory syncytial virus. Immunotechnology. 1996 Sep; 2(3):219-28.
    View in: PubMed
    Score: 0.008
  28. Experimental studies of rhesus monkeys infected with epizootic and enzootic subtypes of Venezuelan equine encephalitis virus. J Infect Dis. 1974 Feb; 129(2):194-200.
    View in: PubMed
    Score: 0.007
  29. Arbovirus studies in Nupeko forest, a possible natural focus of yellow fever virus in Nigeria. I. Description of the area and serological survey of humans and other vertebrate hosts. Trans R Soc Trop Med Hyg. 1974; 68(1):30-8.
    View in: PubMed
    Score: 0.007
  30. Importance of nonhuman primates in yellow fever epidemiology in Nigeria. Trop Geogr Med. 1973 Mar; 25(1):28-38.
    View in: PubMed
    Score: 0.006
  31. The 1970 yellow fever epidemic in Okwoga District, Benue Plateau State, Nigeria. 3. Serological responses in persons with and without pre-existing heterologous group B immunity. Bull World Health Organ. 1973; 49(3):235-44.
    View in: PubMed
    Score: 0.006
  32. Characterization of viruses (Witwatersrand and Germiston) isolated from mosquitoes and rodents collected near Lunyo Forest, Uganda, in 1968. Arch Gesamte Virusforsch. 1972; 38(2):125-32.
    View in: PubMed
    Score: 0.006
  33. Effects of thorotrast on humoral antibody, viral multiplication, and interferon during infection with St. Louis encephalitis virus in mice. J Infect Dis. 1971 Mar; 123(3):297-300.
    View in: PubMed
    Score: 0.005
  34. Comparison of methods for removal of nonspecific inhibitors of arbovirus hemagglutination. Appl Microbiol. 1970 Nov; 20(5):748-53.
    View in: PubMed
    Score: 0.005
  35. Attenuation of wild-type yellow fever virus by passage in HeLa cells. J Gen Virol. 1990 Oct; 71 ( Pt 10):2301-6.
    View in: PubMed
    Score: 0.005
  36. Studies on California encephalitis in Minnesota. Am J Epidemiol. 1970 Jul; 92(1):40-50.
    View in: PubMed
    Score: 0.005
  37. Cross-neutralization tests among Cache Valley virus isolates revealing the existence of multiple subtypes. Am J Trop Med Hyg. 1988 Aug; 39(2):202-5.
    View in: PubMed
    Score: 0.005
  38. Human infections with Tensaw virus in south Florida: evidence that Tensaw virus subtypes stimulate the production of antibodies reactive with closely related Bunyamwera serogroup viruses. Am J Trop Med Hyg. 1988 Jul; 39(1):117-22.
    View in: PubMed
    Score: 0.005
  39. Reevaluation of the western equine encephalitis antigenic complex of alphaviruses (family Togaviridae) as determined by neutralization tests. Am J Trop Med Hyg. 1988 Mar; 38(2):447-52.
    View in: PubMed
    Score: 0.004
  40. A newly recognized vesiculovirus, Calchaqui virus, and subtypes of Melao and Maguari viruses from Argentina, with serologic evidence for infections of humans and horses. Am J Trop Med Hyg. 1987 Jan; 36(1):114-9.
    View in: PubMed
    Score: 0.004
  41. Epizootic vesicular stomatitis in Colorado, 1982: infection in occupational risk groups. Am J Trop Med Hyg. 1987 Jan; 36(1):177-82.
    View in: PubMed
    Score: 0.004
  42. Epizootic vesicular stomatitis in Colorado, 1982: epidemiologic studies along the northern Colorado front range. Am J Trop Med Hyg. 1987 Jan; 36(1):183-8.
    View in: PubMed
    Score: 0.004
  43. Investigations of the vertebrate hosts of eastern equine encephalitis during an epizootic in Michigan, 1980. Am J Trop Med Hyg. 1985 Nov; 34(6):1190-202.
    View in: PubMed
    Score: 0.004
  44. Arbovirus investigations in Argentina, 1977-1980. III. Identification and characterization of viruses isolated, including new subtypes of western and Venezuelan equine encephalitis viruses and four new bunyaviruses (Las Maloyas, Resistencia, Barranqueras, and Antequera). Am J Trop Med Hyg. 1985 Sep; 34(5):956-65.
    View in: PubMed
    Score: 0.004
  45. Reported encephalitis associated with California serogroup virus infections in the United States, 1963-1981. Prog Clin Biol Res. 1983; 123:31-41.
    View in: PubMed
    Score: 0.003
  46. Identification of a new Venezuelan equine encephalitis virus from Brazil. Am J Trop Med Hyg. 1982 Nov; 31(6):1260-72.
    View in: PubMed
    Score: 0.003
  47. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg. 1977; 71(1):60-5.
    View in: PubMed
    Score: 0.002
  48. Bwamba virus infection: a sero-survey of veterbrates in five ecological zones in Nigeria. Trans R Soc Trop Med Hyg. 1974; 68(6):461-5.
    View in: PubMed
    Score: 0.002
  49. Studies on Tataguine infection in Nigeria. Trop Geogr Med. 1972 Sep; 24(3):298-302.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.